I seem to recall that at one of the investor presentations Al stated their intent, at this time, was to submit type 1 and 2 at the same time. He said type 1 trials would get a head start, but then typre 2 would catch up. Then he went on to say that they would reevaluate seperate submissions as circumstances dictated. The delays in type 2 recruiting may just be those circumstances.